Fundraising FoxEtcembly
Harwell, Oxfordshire, GB · 1 known investors
Find your way into Etcembly
Sign up to see every warm intro you have to Etcembly
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Etcembly team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Etcembly builds EMLy Co-pilot, an AI platform with a conversational interface that unifies biologics design workflows—including structural modeling, variant generation, and molecule optimization—into a single tool. It serves biotechs and R&D organizations working on therapeutic candidates such as antibodies (mAbs) and TCRs.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountPrivate Seed FundingApr 2026Source ↗
- Undisclosed amountPrivate Seed FundingFeb 2022Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Companies House · registry record
View on Companies House ↗- Registered name
- ETCEMBLY LTD
- Company number
- 12059749
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 19 Jun 2019
- Registered office
- Etcembly Ltd Quad One, Becquerel Avenue, Harwell Campus, Oxfordshire, OX11 0RA
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 30 Jun 2025 · next due 31 Mar 2027
- Confirmation statement
- last made up to 26 Feb 2026 · next due 12 Mar 2027
Current officers · 5
- Nicholas John Cross — director, appointed 12 Apr 2021
- Donald Anthony Ewer — director, appointed 12 Apr 2021
- Jacob Hurst — director, appointed 1 Aug 2019
- Hamish Alexander Laing — director, appointed 2 Dec 2025
- Michelle Su-Wei Teng — director, appointed 19 Jun 2019
Source: Companies House public register · retrieved 20 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Etcembly do?
- Etcembly builds EMLy Co-pilot, an AI platform with a conversational interface that unifies biologics design workflows—including structural modeling, variant generation, and molecule optimization—into a single tool. It serves biotechs and R&D organizations working on therapeutic candidates such as antibodies (mAbs) and TCRs.
- Who are Etcembly's investors?
- Etcembly's investors include Oxford Technology Management.
- Where is Etcembly headquartered?
- Etcembly is headquartered in Harwell, Oxfordshire, GB.